These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28066934)

  • 1. Acute pain in adolescents and young adults with sickle cell disease: Delayed and increased opioid dosing following transition to adult care.
    Stehouwer N; Edge P; Katie Park B; Piccone C; Little J
    Am J Hematol; 2017 Apr; 92(4):E40-E42. PubMed ID: 28066934
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of the acute painful crisis in sickle cell disease- a re-evaluation of the use of opioids in adult patients.
    Telfer P; Bahal N; Lo A; Challands J
    Br J Haematol; 2014 Jul; 166(2):157-64. PubMed ID: 24750050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Still seeking balance in opioid management for acute sickle cell disease pain.
    Fasipe TA; Hulbert ML
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29741. PubMed ID: 35522166
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.
    Molokie RE; Montminy C; Dionisio C; Farooqui MA; Gowhari M; Yao Y; Suarez ML; Ezenwa MO; Schlaeger JM; Wang ZJ; Wilkie DJ
    Am J Emerg Med; 2018 Jan; 36(1):88-92. PubMed ID: 28802541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid utilization patterns in United States individuals with sickle cell disease.
    Ballas SK; Kanter J; Agodoa I; Howard R; Wade S; Noxon V; Dampier C
    Am J Hematol; 2018 Oct; 93(10):E345-E347. PubMed ID: 30051929
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis.
    Payne J; Aban I; Hilliard LM; Madison J; Bemrich-Stolz C; Howard TH; Brandow A; Waite E; Lebensburger JD
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27420. PubMed ID: 30151977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal fentanyl works-Why are we not using it more to treat acute pain in sickle cell disease?
    Oni MO; Archer NM
    Am J Hematol; 2023 Apr; 98(4):564-565. PubMed ID: 36746630
    [No Abstract]   [Full Text] [Related]  

  • 8. Opioid treatment for acute and chronic pain in patients with sickle cell disease.
    Carroll CP
    Neurosci Lett; 2020 Jan; 714():134534. PubMed ID: 31593753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient pain clinic and intranasal fentanyl to improve sickle cell disease outcomes.
    Myrick R; Blakemore S; Waite E; Pernell B; Madan-Swain A; Hilliard L; Lebensburger J
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28648. PubMed ID: 32798305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating palliative care and emergency medicine for optimal management of sickle cell pain in the wake of the United States opioid epidemic.
    Effiong A; Kumari P
    Ann Palliat Med; 2018 Apr; 7(2):274-276. PubMed ID: 29307211
    [No Abstract]   [Full Text] [Related]  

  • 11. Ketamine and lidocaine infusions decrease opioid consumption during vaso-occlusive crisis in adolescents with sickle cell disease.
    Puri L; Morgan KJ; Anghelescu DL
    Curr Opin Support Palliat Care; 2019 Dec; 13(4):402-407. PubMed ID: 31157658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary for Patients: Treating Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department.
    Ann Intern Med; 2021 Sep; 174(9):I14. PubMed ID: 34224269
    [No Abstract]   [Full Text] [Related]  

  • 13. Pilot study of human recombinant hyaluronidase-enhanced subcutaneous hydration and opioid administration for sickle cell disease acute pain episodes.
    Sandoval M; Coleman P; Govani R; Siddiqui S; Todd KH
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):10-8. PubMed ID: 23527666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients?
    Nobrega R; Carullo V; Thein SL; Quezado ZMN
    Expert Rev Hematol; 2022 Oct; 15(10):887-891. PubMed ID: 36191299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose hydroxyurea is effective in reducing the incidence of painful crisis and frequency of blood transfusion in sickle cell anemia patients from eastern India.
    Patel DK; Mashon RS; Patel S; Das BS; Purohit P; Bishwal SC
    Hemoglobin; 2012; 36(5):409-20. PubMed ID: 22881992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily home opioid use in adults with sickle cell disease: The PiSCES project.
    Smith WR; McClish DK; Dahman BA; Levenson JL; Aisiku IP; de A Citero V; Bovbjerg VE; Roberts JD; Penberthy LT; Roseff SD
    J Opioid Manag; 2015; 11(3):243-53. PubMed ID: 25985809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell disease pain management in adolescents: a literature review.
    Wilson BH; Nelson J
    Pain Manag Nurs; 2015 Apr; 16(2):146-51. PubMed ID: 25175555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell anemia and pain: will data prevail over beliefs?
    Payne R
    Ann Emerg Med; 2009 May; 53(5):596-7. PubMed ID: 19380037
    [No Abstract]   [Full Text] [Related]  

  • 19. Massive hyperhomocysteinaemia as a complication of nitrous oxide inhalation.
    Faguer S; Ruiz J; Mari A
    Br J Clin Pharmacol; 2016 Feb; 81(2):391-2. PubMed ID: 26521848
    [No Abstract]   [Full Text] [Related]  

  • 20. Sickle cell disease related pain: crisis and conflict.
    Todd KH; Green C; Bonham VL; Haywood C; Ivy E
    J Pain; 2006 Jul; 7(7):453-8. PubMed ID: 16814684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.